VPT-0160
QUESTION
A non-selective COX inhibitor investigated as a drug to treat transitional cell carcinoma of bladder?
OPTIONS
(A) Carboplatin
(B) Cisplatin
(C) Piroxicam
(D) Mitoxantrone
ANSWER
(C) Piroxicam
EXPLANATION
Piroxicam is a nonselective cyclooxygenase inhibitor that has been investigated and used as an adjunct in canine transitional cell carcinoma of the bladder. Carboplatin, cisplatin, and mitoxantrone are antineoplastic drugs but are not the nonselective COX inhibitor described.
Question Navigator
Veterinary Pharmacology and Toxicology · 167 Questions
160
/
167
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167